AAAAAA
Results:
1-13
|
Results: 13
Authors:
Kalden, JR
Scott, DL
Smolen, JS
Schattenkirchner, M
Rozman, B
Williams, BD
Kvien, TK
Jones, P
Williams, RB
Oed, C
Rosenburg, R
Citation: Jr. Kalden et al., Improved functional ability in patients with rheumatoid arthritis - Longterm treatment with leflunomide versus sulfasalazine, J RHEUMATOL, 28(9), 2001, pp. 1983-1991
Authors:
Larsen, A
Kvien, TK
Schattenkirchner, M
Rau, R
Scott, DL
Smolen, JS
Rozman, B
Westhovens, R
Tikly, M
Oed, C
Rosenburg, R
Citation: A. Larsen et al., Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine, SC J RHEUM, 30(3), 2001, pp. 135-142
Authors:
Anders, HJ
Sigl, T
Schattenkirchner, M
Citation: Hj. Anders et al., Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope, ANN RHEUM D, 60(4), 2001, pp. 407-409
Authors:
Boeger, CA
Wittwer, H
Schattenkirchner, M
Kellner, H
Kellner, W
Citation: Ca. Boeger et al., Treatment of ankylosing spondylitis with infliximab, ANN RHEUM D, 60(12), 2001, pp. 1159-1160
Authors:
Scott, DL
Smolen, JS
Kalden, JR
van de Putte, LBA
Larsen, A
Kvien, TK
Schattenkirchner, M
Nash, P
Oed, C
Loew-Friedrich, I
Citation: Dl. Scott et al., Treatment of active rheumatoid arthritis with leflunomide: two year followup of a double blind, placebo controlled trial versus sulfasalazine, ANN RHEUM D, 60(10), 2001, pp. 913-923
Authors:
Jelinek, T
Wastlhuber, J
Proll, S
Schattenkirchner, M
Loscher, T
Citation: T. Jelinek et al., Influence of rheumatoid factor on the specificity of a rapid immunochromatographic test for diagnosing dengue infection, EUR J CL M, 19(7), 2000, pp. 555-556
Authors:
Anders, HJ
Rihl, M
Loch, O
Schattenkirchner, M
Citation: Hj. Anders et al., Prediction of creatinine clearance from serum creatinine in patients with rheumatoid arthritis: Comparison of six formulae and one nomogram, CLIN RHEUMA, 19(1), 2000, pp. 26-29
The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review
Authors:
Schattenkirchner, M
Citation: M. Schattenkirchner, The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review, IMMUNOPHARM, 47(2-3), 2000, pp. 291-298
Authors:
Anders, HJ
Schattenkirchner, M
Citation: Hj. Anders et M. Schattenkirchner, Destructive joint lesions and bursitis in idiopathic hypereosinophilic syndrome, RHEUMATOLOG, 38(2), 1999, pp. 185-186
Authors:
Segerer, S
Dietz-Laukemann, P
Schattenkirchner, M
Citation: S. Segerer et al., RS3PE syndrome, Z RHEUMATOL, 58(1), 1999, pp. 35-38
Authors:
Anders, HJ
Rihl, M
Heufelder, A
Loch, O
Schattenkirchner, M
Citation: Hj. Anders et al., Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis, METABOLISM, 48(6), 1999, pp. 745-748
Authors:
Mack, M
Bruhl, H
Gruber, R
Jaeger, C
Cihak, J
Eiter, V
Plachy, J
Stangassinger, M
Uhlig, K
Schattenkirchner, M
Schlondorff, D
Citation: M. Mack et al., Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis, ARTH RHEUM, 42(5), 1999, pp. 981-988
Authors:
Dougados, M
Combe, B
Cantagrel, A
Goupille, P
Olive, P
Schattenkirchner, M
Meussr, S
Paimela, L
Rau, R
Zeidler, H
Leirisalo-Repo, M
Peldan, K
Citation: M. Dougados et al., Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components, ANN RHEUM D, 58(4), 1999, pp. 220-225
Risultati:
1-13
|